We are live on ! Find out more
HCPC

Hamilton Capital Partners (Canada) Portfolio holdings

AUM $3.45B
1-Year Est. Return 58.23%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+58.23%
3 Year Est. Return
+142.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$217M
Cap. Flow
+$241M
Cap. Flow %
15.5%
Top 10 Hldgs %
36.15%
Holding
213
New
35
Increased
91
Reduced
78
Closed
6

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$53.7M
2
PLTR icon
Palantir
PLTR
+$22.6M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$22.2M
4
MA icon
Mastercard
MA
+$20.4M
5
COST icon
Costco
COST
+$20M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$19.2M
2
PG icon
Procter & Gamble
PG
+$16M
3
CAT icon
Caterpillar
CAT
+$16M
4
LIN icon
Linde
LIN
+$15.7M
5
ADBE icon
Adobe
ADBE
+$6.56M

Sector Composition

Rank Sector Weight
1 Technology 24.58%
2 Financials 12.76%
3 Healthcare 8.82%
4 Energy 8.51%
5 Communication Services 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXP icon
76
American Express
AXP
$231B
$4.27M 0.27%
15,856
+3,387
+27% +$1M
MDT icon
77
Medtronic
MDT
$117B
$4.2M 0.27%
46,722
+3,130
+7% +$280K
GILD icon
78
Gilead Sciences
GILD
$172B
$4.18M 0.27%
37,347
-6,831
-15% -$705K
ABT icon
79
Abbott
ABT
$193B
$4.16M 0.27%
31,377
-2,808
-8% -$357K
CI icon
80
Cigna
CI
$74.7B
$4.11M 0.26%
12,480
+1,424
+13% +$429K
ABBV icon
81
AbbVie
ABBV
$441B
$4.08M 0.26%
19,481
-579
-3% -$113K
ELV icon
82
Elevance Health
ELV
$86.8B
$4.05M 0.26%
9,320
+1,937
+26% +$778K
BMY icon
83
Bristol-Myers Squibb
BMY
$130B
$4M 0.26%
65,556
-5,999
-8% -$350K
MRK icon
84
Merck
MRK
$335B
$3.98M 0.26%
44,321
+10,427
+31% +$974K
CVS icon
85
CVS Health
CVS
$124B
$3.97M 0.25%
+58,614
New +$3.51M
AMGN icon
86
Amgen
AMGN
$225B
$3.96M 0.25%
12,707
+1,012
+9% +$299K
SYK icon
87
Stryker
SYK
$130B
$3.96M 0.25%
10,625
-195
-2% -$74.2K
PFE icon
88
Pfizer
PFE
$153B
$3.94M 0.25%
155,677
+22,082
+17% +$578K
BSX icon
89
Boston Scientific
BSX
$75.1B
$3.92M 0.25%
38,845
-7,730
-17% -$778K
ISRG icon
90
Intuitive Surgical
ISRG
$139B
$3.88M 0.25%
7,834
-101
-1% -$55.9K
DHR icon
91
Danaher
DHR
$142B
$3.86M 0.25%
18,815
+4,499
+31% +$982K
TMO icon
92
Thermo Fisher Scientific
TMO
$218B
$3.82M 0.25%
7,682
+1,242
+19% +$673K
VRTX icon
93
Vertex Pharmaceuticals
VRTX
$128B
$3.77M 0.24%
7,774
-337
-4% -$157K
O icon
94
Realty Income
O
$59.4B
$3.16M 0.2%
54,528
+7,424
+16% +$411K
WELL icon
95
Welltower
WELL
$170B
$2.92M 0.19%
19,059
-4,228
-18% -$602K
AMT icon
96
American Tower
AMT
$81.8B
$2.92M 0.19%
13,418
+640
+5% +$126K
PSA icon
97
Public Storage
PSA
$60.9B
$2.9M 0.19%
9,691
+1,495
+18% +$447K
SPG icon
98
Simon Property Group
SPG
$71B
$2.87M 0.18%
17,282
-3
-0% -$524
CCI icon
99
Crown Castle
CCI
$32.3B
$2.85M 0.18%
27,388
+1,659
+6% +$155K
DLR icon
100
Digital Realty Trust
DLR
$74.1B
$2.82M 0.18%
19,667
+2,302
+13% +$374K
2 3
4
5 6

Similar funds

MC
Metropolis Capital Amersham, United Kingdom $3.45B AUM 1.26% 1-Year Est. Return
SCM
Silvant Capital Management Atlanta, Georgia $3.44B AUM 36.06% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.45B AUM 27.72% 1-Year Est. Return
CAM
Camden Asset Management Los Angeles, California $3.43B AUM 14.75% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.43B AUM 37.73% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $3.46B AUM 30.37% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s Q1 2025 Portfolio in Review

As of Q1 2025, Hamilton Capital Partners (Canada) held 213 positions worth $1.56B, up 16% from $1.34B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Hamilton Capital Partners (Canada) deployed $241M of net new capital in Q1 2025, opening 35 new positions and adding to 91 existing holdings. Its largest new stake was Palantir: 257,902 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $16M trimmed.

  • Hamilton Capital Partners (Canada)'s largest Q1 2025 buy was Palantir: 257,902 shares worth $21.8M.
  • Hamilton Capital Partners (Canada) added most to iShares 0-3 Month Treasury Bond ETF in Q1 2025, an estimated $53.7M increase.
  • Hamilton Capital Partners (Canada)'s biggest Q1 2025 reduction was Procter & Gamble, cutting an estimated $16M.
  • Hamilton Capital Partners (Canada) fully exited Applied Materials in Q1 2025, selling an estimated $19.2M.
  • Hamilton Capital Partners (Canada)'s ten largest holdings make up 36% of its $1.56B portfolio in Q1 2025.
  • Hamilton Capital Partners (Canada) opened 35 new positions and closed 6 in Q1 2025.
  • Hamilton Capital Partners (Canada)'s portfolio value rose 16% quarter-over-quarter to $1.56B.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q1 2025, filed 14 Aug 2026.